Elevated levels of the acute‐phase serum amyloid are associated with heightened lung cancer risk
暂无分享,去创建一个
C. la Vecchia | U. Pastorino | C. Verri | G. Sozzi | M. Pierotti | E. Calabró | G. Randi | I. Bongarzone | P. Mondellini | M. De Bortoli | M. Cremona
[1] D. Chan,et al. Identification of Biomarkers for Breast Cancer in Nipple Aspiration and Ductal Lavage Fluid , 2005, Clinical Cancer Research.
[2] William L. Bigbee,et al. Diagnostic Accuracy of MALDI Mass Spectrometric Analysis of Unfractionated Serum in Lung Cancer , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[3] B. Adam,et al. Serum protein profile analysis in patients with head and neck squamous cell carcinoma. , 2006, Archives of otolaryngology--head & neck surgery.
[4] Ugo Pastorino,et al. Computed tomography screening and lung cancer outcomes. , 2007, JAMA.
[5] T. Yip,et al. Identification of Serum Amyloid A Protein As a Potentially Useful Biomarker to Monitor Relapse of Nasopharyngeal Cancer by Serum Proteomic Profiling , 2004, Clinical Cancer Research.
[6] Weijian Guo,et al. Prediction of Pancreatic Cancer by Serum Biomarkers Using Surface-Enhanced Laser Desorption/Ionization-Based Decision Tree Classification , 2005, Oncology.
[7] R. Badolato,et al. Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes , 1994, The Journal of experimental medicine.
[8] F. D. de Beer,et al. Human serum amyloid A (SAA) protein: a prominent acute‐phase reactant for clinical practice , 1996, European journal of clinical investigation.
[9] Victor G Zgoda,et al. Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1 , 2005, Proteomics.
[10] Wei Zhang,et al. Application of serum SELDI proteomic patterns in diagnosis of lung cancer , 2005, BMC Cancer.
[11] Carole Mathelin,et al. Serum biomarkers for detection of breast cancers: a prospective study , 2006, Breast Cancer Research and Treatment.
[12] D. Smallwood,et al. Serum amyloid a is a biomarker of acute exacerbations of chronic obstructive pulmonary disease. , 2008, American journal of respiratory and critical care medicine.
[13] M. Pierotti,et al. RET oncoproteins induce tyrosine phosphorylation changes of proteins involved in RNA metabolism. , 2006, Cellular signalling.
[14] T. Yip,et al. New desorption strategies for the mass spectrometric analysis of macromolecules , 1993 .
[15] D. Metcalfe,et al. Extracellular matrix-anchored serum amyloid A preferentially induces mast cell adhesion. , 1997, The American journal of physiology.
[16] P. Simpson,et al. Statistical methods in cancer research , 2001, Journal of surgical oncology.
[17] S. Flibotte,et al. Identification of serum amyloid A as a biomarker to distinguish prostate cancer patients with bone lesions. , 2005, Clinical chemistry.
[18] E. Malle,et al. Serum amyloid A: An acute-phase protein involved in tumour pathogenesis , 2008, Cellular and Molecular Life Sciences.
[19] Jiekai Yu,et al. SELDI-TOF-MS: the proteomics and bioinformatics approaches in the diagnosis of breast cancer. , 2005, Breast.
[20] Ron Kohavi,et al. A Study of Cross-Validation and Bootstrap for Accuracy Estimation and Model Selection , 1995, IJCAI.
[21] C. Maury,et al. Comparative study of serum amyloid A protein and C-reactive protein in disease. , 1985, Clinical science.
[22] W. Y. Zhang,et al. Serum proteomic features for detection of endometrial cancer , 2005, International Journal of Gynecologic Cancer.
[23] M. Campa,et al. Clinical utility of serum amyloid A and macrophage migration inhibitory factor as serum biomarkers for the detection of nonsmall cell lung carcinoma , 2004, Cancer.
[24] P. Sharp,et al. Evolution of the serum amyloid A (SAA) protein superfamily. , 1994, Genomics.
[25] N. Breslow,et al. Statistical methods in cancer research: volume 1- The analysis of case-control studies , 1980 .
[26] T. Yamada,et al. Serum Amyloid A (SAA): a Concise Review of Biology, Assay Methods and Clinical Usefulness , 1999, Clinical chemistry and laboratory medicine.
[27] D. Hayes,et al. Uses and abuses of tumor markers in the diagnosis, monitoring, and treatment of primary and metastatic breast cancer. , 2006, The oncologist.
[28] Shu Zheng,et al. Application of serum protein fingerprint in diagnosis of papillary thyroid carcinoma , 2006, Proteomics.
[29] Susan R. Wilson,et al. Proteomic classification of pancreatic adenocarcinoma tissue using protein chip technology. , 2006, Gastroenterology.
[30] Robert Tibshirani,et al. The Use of Plasma Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Proteomic Patterns for Detection of Head and Neck Squamous Cell Cancers , 2004, Clinical Cancer Research.